Exco Intouch To Co-Host Innovative Seminar Series Showcasing The Impact Of Epro And Compliance Technology For Clinical Trials
Main Category: Clinical Trials / Drug TrialsAlso Included In: Pharmacy / Pharmacist
Article Date: 22 Apr 2009 - 6:00 PDT
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
Exco InTouch, the leading provider of patient communication solutions for the pharmaceutical and healthcare sectors, announces that the company will co-host two informative seminars examining the impact new technology has had on patient engagement in clinical trials. The first event will be held at the Marriott Downtown, Philadelphia, US on April 21 2009. A UK event will follow on May 13, 2009 at The Cumberland Hotel in London. Delegates can register for these events by visiting http://www.regonline.com/ePRO_Philadelphia (Philadelphia) and http://www.regonline.com/ePRO_London(London). The seminar series is also being led by ERT, a leading provider of centralized ECG and eClinical technology, ePRO and services to the biopharmaceutical, medical device and related industries.
The half-day seminars, entitled 'The Complete Patient Experience throughout the Trial Lifecycle', will feature interactive discussions led by key industry figures. Exco InTouch CEO Tim Davis will examine the issues of cell phone technology, security and patient confidentiality and the future of new clinical trial technologies. Exco InTouch will also share several real-world retention and ePRO case studies to demonstrate the benefits of cell phone technology for use in clinical trials. Exco InTouch representatives will be on hand at the seminar to give an overview of how the company is harnessing the power of a patient's own cell phone to deliver eDiaries - a more successful and cost-effective alternative to other methods of data collection.
Ken Kaitin, Director and Professor of Medicine Tufts Center for the Study of Drug Development at TUFTS University in Massachusetts, will deliver a keynote address at both seminars entitled 'Pharmaceutical Innovation at a Crossroads: Economic and Political Perspectives on the New Drug Development Process'. Other speakers at the event will include John H. Greist, Director at Healthcare Technology Systems Inc, who will be discussing Interactive Voice Response technology in suicidality assessments.
Exco InTouch's cell phone-based electronic Patient Reported Outcomes (ePRO), recruitment, retention and compliance offerings have already helped several large pharmaceutical companies to enhance clinical trial communications and substantially improve data capture.
For further information on the Exco InTouch seminar series and the company's extensive portfolio of patient communication solutions please call +44 1279 408 210 or +1 949 725 2946 or visit http://www.excointouch.com.
About Exco InTouch
Exco InTouch is the leading provider of interactive patient communication solutions using internet and cell phone technology. Using a combination of software and services, Exco InTouch offers BioPharma sponsors, CROs and patient recruitment agencies the opportunity to improve patient recruitment, retention and compliance using timely notifications, alerts and two-way messages.
Additionally, Exco collects electronic patient reported outcomes (ePRO) and diary data using standard cell phone technology which is both cost effective for sponsors and extremely easy and convenient for trial subjects. These solutions are currently being used by hundreds of thousands of patients in over 70 countries, delivered in the local language and are fully compliant with HIPAA regulations, FDA CFR 21 Part 11 and all electronic communication privacy directives.
Source
Exco InTouch
Visit our clinical trials / drug trials section for the latest news on this subject.
MLA
16 Feb. 2012. <http://www.medicalnewstoday.com/releases/147030.php>
APA
http://www.medicalnewstoday.com/releases/147030.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



